RE: Clinical implication of detected tachyarrhythmias in patients with implantable cardioverter defibrillators

Documenti analoghi

• Quality of life and acceptance of the extravascular implantable cardioverter‐defibrillator
  di: Razan Dankar, et al.
  Pubblicazione: (2024)
• Risk stratification for ventricular tachyarrhythmia in patients with nonischemic cardiomyopathy
  di: Ido Goldenberg, et al.
  Pubblicazione: (2024)
• The impact of supraventricular arrhythmias on the outcomes of guideline‐compliant implantable cardioverter defibrillator programming
  di: Padoemwut Teerawongsakul, et al.
  Pubblicazione: (2024)
• The clinical and economic impact of extended battery longevity of the extravascular implantable cardioverter defibrillator
  di: Razan Dankar, et al.
  Pubblicazione: (2024)
• The clinical and economic impact of extended battery longevity of a substernal extravascular implantable cardioverter defibrillator
  di: Stuart Mealing, et al.
  Pubblicazione: (2024)